Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing

dc.contributor.authorSiripipattanamongkol N.
dc.contributor.authorRattanasak S.
dc.contributor.authorTaiyaitieng C.
dc.contributor.authorInthajak Y.
dc.contributor.authorKuawatcharawong N.
dc.contributor.authorSukasem C.
dc.contributor.authorTempark T.
dc.contributor.otherMahidol University
dc.date.accessioned2023-06-20T05:28:54Z
dc.date.available2023-06-20T05:28:54Z
dc.date.issued2022-07-01
dc.description.abstractToxic epidermal necrolysis (TEN) is a rare and acute life-threatening condition and one of the severe cutaneous adverse drug reactions. There are limited data on TEN from the COVID-19 vaccine regarding its pathogenesis, treatment, and prognosis, particularly in children. We report a case of COVID-19 vaccine-induced TEN and the patient's human leukocyte antigen pharmacogenomic profile.
dc.identifier.citationPediatric Dermatology Vol.39 No.4 (2022) , 601-605
dc.identifier.doi10.1111/pde.15074
dc.identifier.eissn15251470
dc.identifier.issn07368046
dc.identifier.pmid36000937
dc.identifier.scopus2-s2.0-85136479357
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/87280
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleToxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85136479357&origin=inward
oaire.citation.endPage605
oaire.citation.issue4
oaire.citation.startPage601
oaire.citation.titlePediatric Dermatology
oaire.citation.volume39
oairecerif.author.affiliationUniversity of Liverpool
oairecerif.author.affiliationBumrungrad International Hospital
oairecerif.author.affiliationFaculty of Medicine Ramathibodi Hospital, Mahidol University
oairecerif.author.affiliationFaculty of Medicine, Chulalongkorn University
oairecerif.author.affiliationChiangrai Prachanukroh Hospital

Files

Collections